| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pain | D010146 | 64 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Heart Failure | D006333 | 36 associated lipids |
| Facial Dermatoses | D005148 | 7 associated lipids |
| Acne Vulgaris | D000152 | 35 associated lipids |
| Melanoma | D008545 | 69 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
Azelaic acid
Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.
Cross Reference
Introduction
To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azelaic acid?
Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azelaic acid
PubChem Associated disorders and diseases
What pathways are associated with Azelaic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azelaic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azelaic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azelaic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azelaic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azelaic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Azelaic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Satoh M et al. | Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. | 2007 | Circulation | pmid:17562954 |
| Alsantali A | Alopecia areata: a new treatment plan. | 2011 | Clin Cosmet Investig Dermatol | pmid:21833161 |
| Keri J and Shiman M | An update on the management of acne vulgaris. | 2009 | Clin Cosmet Investig Dermatol | pmid:21436973 |
| Whitney KM and Ditre CM | Management strategies for acne vulgaris. | 2011 | Clin Cosmet Investig Dermatol | pmid:21691566 |
| Purdy S | Acne vulgaris. | 2006 | Clin Evid | pmid:16973084 |
| Purdy S | Acne vulgaris. | 2005 | Clin Evid | pmid:16135322 |
| Bowler PJ | Impact on facial rejuvenation with dermatological preparations. | 2009 | Clin Interv Aging | pmid:19503770 |
| Craythorne EE and Lawrence CM | Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna. | 2008 | Clin Med Oncol | pmid:21892331 |
| Bertuzzi A et al. | Pharmacokinetic analysis of azelaic acid disodium salt. A proposed substrate for total parenteral nutrition. | 1991 | Clin Pharmacokinet | pmid:1908756 |
| Spellman MC and Pincus SH | Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne. | 1998 Jul-Aug | Clin Ther | pmid:9737831 |
| Lowe NJ et al. | Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. | 1998 Sep-Oct | Clin Ther | pmid:9829446 |
| Kakita LS and Lowe NJ | Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. | 1998 Sep-Oct | Clin Ther | pmid:9829447 |
| Capristo E et al. | A new HPLC method for the direct analysis of triglycerides of dicarboxylic acids in biological samples. | 1999 | Clin. Chim. Acta | pmid:10556649 |
| Breathnach AC et al. | Azelaic acid therapy in disorders of pigmentation. | 1989 Apr-Jun | Clin. Dermatol. | pmid:2667735 |
| Sowden J et al. | Malignant melanoma arising in the scar of lupus vulgaris and response to treatment with topical azelaic acid. | 1988 | Clin. Exp. Dermatol. | pmid:3256454 |
| Nazzaro-Porro M et al. | A case of recurrent (following surgery x2) invasive malignant melanoma with satellitosis (stage IIIA) successfully resolving after azelaic acid treatment administered by several routes. | 1996 | Clin. Exp. Dermatol. | pmid:8959915 |
| Samycia M and Lam JM | Infantile acne. | 2016 | CMAJ | pmid:27873756 |
| van Zuuren EJ et al. | Interventions for rosacea. | 2011 | Cochrane Database Syst Rev | pmid:21412882 |
| van Zuuren EJ et al. | Interventions for rosacea. | 2015 | Cochrane Database Syst Rev | pmid:25919144 |
| Shah J | Plants under attack: systemic signals in defence. | 2009 | Curr. Opin. Plant Biol. | pmid:19608451 |
| Pazoki-Toroudi H et al. | Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. | 2011 | Cutan Ocul Toxicol | pmid:21612319 |
| Del Rosso JQ | A status report on the medical management of rosacea: focus on topical therapies. | 2002 | Cutis | pmid:12469780 |
| Wolf JE | The role of topical metronidazole in the treatment of rosacea. | 2004 | Cutis | pmid:14959942 |
| Del Rosso JQ | Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. | 2010 | Cutis | pmid:21229827 |
| Del Rosso JQ et al. | Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model. | 2009 | Cutis | pmid:19363903 |
| Del Rosso JQ | The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. | 2009 | Cutis | pmid:19746764 |
| Elewski BE | Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%. | 2007 | Cutis | pmid:17330623 |
| Del Rosso JQ and Bhatia N | Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. | 2011 | Cutis | pmid:21916272 |
| Del Rosso JQ et al. | Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. | 2006 | Cutis | pmid:17354468 |
| Colón LE et al. | Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. | 2007 | Cutis | pmid:17500380 |
| Wolf JE | Present and future rosacea therapy. | 2005 | Cutis | pmid:15810803 |
| van Zuuren EJ and Graber MA | The rigor of trials evaluating Rosacea treatments. | 2005 | Cutis | pmid:15810805 |
| Draelos ZD | Noxious sensory perceptions in patients with mild to moderate rosacea treated with azelaic acid 15% gel. | 2004 | Cutis | pmid:15551720 |
| Fleischer AB | The evolution of azelaic acid. | 2006 | Cutis | pmid:16566281 |
| Draelos ZD | The rationale for advancing the formulation of azelaic acid vehicles. | 2006 | Cutis | pmid:16566282 |
| Elewski B and Thiboutot D | A clinical overview of azelaic acid. | 2006 | Cutis | pmid:16566283 |
| Bikowski JB | Case studies. | 2006 | Cutis | pmid:16566284 |
| Del Rosso JQ | The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. | 2006 | Cutis | pmid:16566285 |
| Wolf JE et al. | Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. | 2006 | Cutis | pmid:16706244 |
| Callender VD | Considerations for treating acne in ethnic skin. | 2005 | Cutis | pmid:16164153 |
| Del Rosso JQ et al. | Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. | 2014 | Cutis | pmid:24738094 |
| Draelos ZD et al. | Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study. | 2013 | Cutis | pmid:24416747 |
| Gibson JR | Rationale for the development of new topical treatments for acne vulgaris. | 1996 | Cutis | pmid:8654127 |
| Graupe K et al. | Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. | 1996 | Cutis | pmid:8654128 |
| Breathnach AS | Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. | 1996 | Cutis | pmid:8654129 |
| Lowe NJ | New approaches in dermatology: a clinical profile of azelaic acid. | 1996 | Cutis | pmid:8654130 |
| Rocamora V et al. | Amelanotic lentigo maligna melanoma: report of a case and review of the literature. | 1999 | Cutis | pmid:10431675 |
| Prignano F et al. | Therapeutical approaches in melasma. | 2007 | Dermatol Clin | pmid:17662899 |
| Ely H | Dermatologic therapies you've probably never heard of. | 1989 | Dermatol Clin | pmid:2646047 |
| Cayce KA et al. | Hyperpigmentation: an overview of the common afflictions. | 2004 | Dermatol Nurs | pmid:15624705 |